IRF1 and malignant glioma: In particular, IRF1 expression was 33.893-fold higher in malignant glioma (p = 0.008); two additional studies by Liang and Bredel found that IRF1 expression was increased 2.225- and 2.151-fold, respectively, in glioblastoma.